Bringing together world-class researchers to share knowledge
and move research
into action.
Tanya Dawn McDougall
From St. Theresa Point Ansininew Nation
Conference Opening and Closing
Wednesday, October 21, 2026
Thursday, October 22, 2026
Beginning of Day 1, End of Day 2
Tanya Dawn McDougall, M.Ed, M.Ed. hails from St. Theresa Point Ansininew Nation in northern Manitoba. Her traditional name is Dipiskew Geezik, which comes with a gift of perspective. Rooted in traditional teachings and values, Tanya serves her community in the fields of education, research and well-being. Much of her work has required navigating relationships, practice, and worldviews. With a focus on the needs and futures of the children in her community, she dedicates herself passionately as an advocate and support.
We are honoured to begin the conference with opening remarks and a blessing from Tanya McDougall, Indigenous Knowledge Carrier. The conference will conclude with reflections and a closing blessing offered by Tanya McDougall,
Indigenous Knowledge Carrier.
Research Advisory Council for Youth (RACY)
From The Children’s Hospital Research Institute of Manitoba
Quiet, the Kids are Talking: Highlighting the Importance of Youth Engagement Across the Spectrum of Child Health Research
Wednesday, October 21, 2026
9:55 AM – 10:20 AM
Al Gilbert (top left):
Al Gilbert is an emerging transgender performer, originally from Winnipeg, Manitoba. This is Al’s third time participating in CHRIM’s Research Days, but his first time as a presenter. He is dedicated to using his experience
and knowledge with the healthcare system to help those in similar situations, and uplift voices that otherwise wouldn’t be heard. Al is finishing his final year at Sheridan College in Oakville, Ontario for an Honours bachelor’s
in music Theatre Performance, and is elated to connect with open minded and welcoming individuals about the importance of the Youth of today and the future.
Chloé Janse van Rensburg (top right):
Chloé Janse van Rensburg is currently a third-year medical student at the University of Manitoba and completed her B.Sc. with a major in microbiology in 2024. She first got involved in research in 2021 through a research
project with the ENRRICH research theme. Chloé’s lived experience with a chronic disease drives her passion for patient engagement in research, and she is currently a member of CHRIM’s Board of Directors. Chloe has been a
member of CHRIM’s Research Advisory Council for Youth (RACY) for five years and continues to support researchers across disciplines.
Andrew Riley (bottom left):
Andrew Riley is a performer originally from Niverville, Manitoba. This is Andrew’s second time attending CHRIM Research Days, and he is excited to be speaking as a representative of RACY. He looks forward to sharing his experiences
as a youth advocate, as well as his knowledge within the research and healthcare systems.
Madelyne Senécal (bottom right):
Madelyne is a microbiology student, undergraduate research assistant, volleyball coach, and youth research advisor with experience in child health research and knowledge translation. She is passionate about encouraging youth
engagement. By using her voice to help ensure research is accessible, relevant, and informed by the communities it impacts.
This session will welcome attendees to the CHRIM research community and introduce the institute’s Research Advisory Council for Youth (RACY). Together, five members of RACY will share their experiences as advisors on the council, highlighting the role of the council in supporting CHRIM researchers. From cells to society, this session will demonstrate the importance of engaging young people and families in child health research across a broad spectrum of research areas.
Dr. Jacquetta Trasler
From McGill University
Healthy Fathers – Healthy Children
Wednesday, October 21, 2026
10:25 AM – 10:50 AM
Jacquetta Trasler is a Distinguished James McGill Professor Emerita in the Departments of Pediatrics, Human Genetics and Pharmacology & Therapeutics at McGill University and a Senior Scientist in the Child Health and Human Development Program at the Research Institute of the McGill University Health Centre (RI-MUHC). She has played key leadership roles including as Director of the McGill MD-PhD Program, Director of Child Health Research at the RI-MUHC and President of the Canadian Fertility and Andrology Society. Her research is in the field of reproductive and developmental epigenomics. She studies how preconception and early life environmental stressors impact the epigenome to predispose children to birth defects and adverse health outcomes.
The epigenome, heritable marks on our DNA that influence gene expression, undergoes its most dynamic programming at key times that influence normal development in children. Altered epigenetic marks or epimutations can be corrected, suggesting the importance of early detection and the development of approaches to prevention. I will discuss our research on mechanisms involved in epigenetic inheritance with a special focus on men’s health and how lifestyle and the environment affect fertility and offspring health.
Nolan De Leon
From the University of Manitoba
Decoding Circular RNA Signatures in Congenital Diaphragmatic Hernia: A New Horizon for Prognosis and Diagnosis
Wednesday, October 21, 2026
10:55 AM – 11:10 AM
Nolan S. De Leon is an M.D./Ph.D. student in physiology and pathophysiology at the University of Manitoba. His work aims to unravel the causes of birth defects by examining epigenetic and transcriptomic factors, particularly circular RNAs, as regulators of disease and potential diagnostic biomarkers. His research on Congenital Diaphragmatic Hernia has garnered international recognition, reflecting his commitment to advancing medical knowledge and leadership in healthcare. Nolan is the recipient of the Doctors Manitoba Top 40 under 40 Award, the Canadian Federation of Medical Students Leadership Award, and the International Michael Höllwarth Pediatric Surgery Award for Best Clinical Research (2025).
This session explores the emerging role of circular RNAs in congenital diaphragmatic hernia (CDH). We will explore how circRNAs in cell-free human amniotic fluid may improve prenatal diagnosis, enable patient risk stratification for treatment decision-making, and provide insights into the molecular mechanisms underlying fetal lung development and CDH pathogenesis.
Dr. Lei Xing
From the University of Manitoba
The First Architect: The Placenta’s Role in Shaping the Human Brain
Wednesday, October 21, 2026
11:15 AM – 11:40 AM
Dr. Lei Xing completed his undergraduate and masters studies at the medical school of Jilin University, China. His strong interest in neuroscience led him to University of Ottawa, where he studied neuroestrogen regulation by neurotransmitters in the adult brain during his Ph.D, under the supervision of Dr. Vance Trudeau. To further understand the role of hormones and neurotransmitters in the developing brain, Dr. Xing joined the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, Germany in 2016, as a postdoctoral researcher. In Dr. Wieland Huttner’s lab, his work using mouse, ferret and human organoid has identified a novel role of serotonin as an extrinsic factor to promote basal progenitor proliferation in the developing human neocortex and also linked the enhanced memory flexibility to the expanded neocortex induced by the human-specific gene ARHGAP11B. In September 2023, Dr. Xing joined the Department of Biological Sciences at University of Manitoba as an Assistant Professor, his research is focused on understanding the cellular and molecular mechanisms underlying the impact of placental factors on brain development, evolution and neurodevelopmental disorders.
The human placenta is a specialized transient organ that plays a critical role in the health and well-being of both the fetus and its mother. Most of the essential functions of the placenta are mediated by the placental hormones and signaling molecules secreted into the maternal circulation and the fetal bloodstream. However, without a doubt, a complete and comprehensive understanding of the full repertoire of hormones and proteins the placenta secretes at specific developmental stages is lacking. My research program is to understand the contribution of placenta-derived cell-extrinsic factors to normal human brain development as well as their imbalance in leading to pregnancy-related conditions and the onset of neurological disorders using mice and human organoid models.
Dr. Sharon Dell
From the University of British Columbia
Clinical & Translational Advances in Genetic Causes of Non-CF Bronchiectasis
Wednesday, October 21, 2026
12:50 PM – 1:15 PM
Sharon Dell is a professor of pediatrics and head, division of respiratory medicine, at the University of British Columbia and BC Children’s Hospital since June 2020. Previously she was professor of pediatrics at SickKids Hospital, where she led the Clinical Epidemiology and Health Care Research MSc/PhD graduate program at the University of Toronto from 2010-2015. Dr. Dell’s research program focuses on evaluating health outcomes, risk factors, genotype/phenotype correlations and diagnostic tests in children with lung disease, with a focus on primary ciliary dyskinesia (PCD) and severe asthma. She has held continuous federal grant funding (NIH, CIHR, Health Canada, CTS) since starting her academic career in 2002. Dr. Dell was recently awarded the Canadian Thoracic Society Honorary Lecture Award, which honors exemplary leadership in respiratory research and education in Canada.
Three learning objectives include:
- Know that primary ciliary dyskinesia (PCD) is a frequent genetic cause of non-cystic fibrosis bronchiectasis associated with high morbidity
- Demonstrate when to suspect and how to diagnose PCD
- Appreciate the dramatically higher incidence of non-CF bronchiectasis and PCD in Indigenous children
Julie-Anne McCarthy
From the University of Manitoba
Examining Mental Health and Protective Factors Among Youth With and Without Child Maltreatment Experiences Using the Canadian Health Survey on Children and Youth(CHSCY)
Wednesday, October 21, 2026
1:20 PM – 1:35 PM
Julie-Anne (she/her) is a Franco-Manitoban PhD candidate in Community Health Sciences with the University of Manitoba. She has an honours degree in Psychology and a Master of Science degree in Community Psychology. Julie-Anne is also a research assistant with the Childhood Adversity and Resilience (CARe team) led by Dr. Tracie Afifi and Dr. Ashley Stewart-Tufescu, and is a trainee representative with the Canadian Academy for Psychiatric Epidemiology. Her experiences and interests include research and program development in adverse childhood experiences, population health, Francophone minority well-being, and promoting mental health for children, youth and families.
This presentation will include information on prevalence of child maltreatment and mental health challenges among youth in Canada, as well as protective factors within the youth’s life that may protect their mental health. Data are drawn from the Canadian Health Survey on Children and Youth which includes youth’s self-reported experiences.
Dr. Bob Schroth
From the University of Manitoba
Early Childhood Caries: Understanding the Burden and Advancing Access to Preventive Care in the Community
Wednesday, October 21, 2026
1:40 PM – 2:05 PM
Dr. Schroth is Professor in the Rady Faculty of Health Sciences, University of Manitoba and Research Scientist at the Children’s Hospital Research Institute of Manitoba. He is a diplomate of the American Board of Dental Public Health and a dental clinician-scientist, practicing out of two community-based clinics in Winnipeg, Manitoba. He is a leading expert on early childhood caries and leads the international Early Childhood Caries Advocacy Group. He holds a Canadian Institutes of Health Research Applied Public Health Chair in Oral Health relating to “Improving Access to Oral Health Care and Oral Health Status for Children in Canada”.
Significant oral health disparities exist in Canada. Nowhere is this more evident than among children from priority populations including low-income households, First Nations, Métis, and Inuit peoples, refugees and recent immigrants, and children living in rural and remote regions of Canada. Unfortunately, poor access to oral health care for very young children often manifests itself as early childhood caries (ECC). ECC is a considerable global public health problem. Children who develop severe forms of ECC and require rehabilitative dental surgery under general anesthesia face additional barriers to accessing timely care. Increasing access to early and preventive oral health care for priority groups of children is critical to address health inequity and curb the ECC epidemic.
Several recent developments in Canada have the potential to dramatically improve access to care and put children on the right path for optimal oral health. These include introduction of silver diamine fluoride, the Canadian Caries Risk Assessment (CRA) Tool for children < 6 years, and the introduction of the Interim Canada Dental Benefit (CDB) and Canadian Dental Care Plan (CDCP).
Learning Objectives:
- Recognize the oral health disparities experienced by young children in Canada, specifically early childhood caries (ECC)
- Understand the key dimensions that determine access to care and the unique access to oral health care challenges facing children in Canada
- Appreciate the role of recent prevention and policy developments targeting children’s oral health in Canada, including:
a. Early childhood oral health promotion
b. Silver diamine fluoride
c. The Canadian Caries Risk Assessment Tool for Children < 6 years of age
d. The Interim Canada Dental Benefit and the Canadian Dental Care Plan
Dr. Karen Fung-Kee-Fung
From the University of Ottawa
Fetal Therapy… a Window of Opportunity for Disease Modification
Wednesday, October 21, 2026
2:10 PM – 2:35 PM
Dr. Karen Fung-Kee-Fung is a Maternal–Fetal Medicine specialist and Professor of Obstetrics and Gynecology at the University of Ottawa and The Ottawa Hospital. Her clinical work focuses on some of the most complex pregnancies, including alloimmune disease, fetal therapy, and complex multiple gestations, which she manages through a specialized weekly clinic while also teaching and mentoring the next generation of MFM specialists.
She is internationally recognized for her expertise in Rhesus alloimmunization and intrauterine transfusion and has led clinical care in this area for over 30 years. Dr. Fung-Kee-Fung also contributed to a landmark advance in fetal therapy as part of the multidisciplinary team involved in the first reported in utero enzyme replacement therapy for infantile-onset Pompe disease.
To be determined
Dr. Ugochi Vivian Ukah
From McGill University
Maternal and Child Health Following Pregnancy Complications
Thursday, October 22, 2026
8:05 AM – 9:00 AM
Dr. Ugochi Vivian Ukah is an Assistant Professor in the Department of Medicine, McGill University. Her research focuses on examining disparities in perinatal outcomes and predicting short- and long-term outcomes of pregnancy complications. Dr Ukah holds a master’s degree in Public Health (health services research) from the University of Sheffield, England and a PhD in Reproductive and Developmental Sciences from the University of British Columbia, Canada. She completed her postdoctoral fellowship at the Department of Epidemiology, Biostatistics, and Occupational Health at McGill University.
In this presentation, Dr. Ukah will highlight some of studies on perinatal outcomes.
Dr. Jennifer Leason
From the University of Calgary
Umbilical Consciousness: Creating Life Holding Systems in First Nations, Inuit, Métis and Indigenous Maternal Child Health
Thursday, October 22, 2026
9:15 AM – 9:40 AM
Dr. Jennifer Leason is an off-reserve member of Minegoziibe Anishinaabe Nation, Manitoba, currently living in Treaty 6 Territory. She is an artist, writer, community-based researcher, farmer and proud mother to Lucas and Lucy.
Dr. Leason is a Canadian Institute of Health Research (CIHR) Canada Research Chair, Tier II, Indigenous Maternal Child Wellness and a Professor at the University of Calgary. Her research aims to address perinatal and maternal-child
health disparities and inequities by examining maternity experiences, healthcare utilization, and social-cultural contexts of First Nations, Métis, Inuit and Indigenous maternal child health and wellness.
Join Dr. Leason as she shares her stories and experiences, teachings, research and data in Indigenous maternal child health over the last 2 decades. Through data, art, love and laughter, this session aims to inform and inspire
hope and a new vision for a shared future.
For more information about Dr. Leason and her program of teaching, artwork, research and scholarship, please visit:
https://www.jenniferleason.com
Dr. Karen Lawford
From McMaster University
Centering Relationality in Health and Care
Thursday, October 22, 2026
9:45 AM – 10:10 AM
Dr. Lawford is an Anishinaabe midwife and enrolled member of Lac Seul First Nation. She is a registered midwife in Ontario and holds a Canada Research Chair in Indigenous Midwifery at McMaster University. Her health systems research advances comprehensive, gender-inclusive sexual and reproductive health grounded in Indigenous theories, methodologies, and methods. A founding member of the National Council of Indigenous Midwives and the Global Council of Indigenous Midwives, she works to influence policy, program, and systems change aligned with the TRC Calls to Action, MMIWG Calls to Justice, and RCAP recommendations. Her scholarship centers Indigenous governance, knowledge systems, and culturally grounded care.?
Relationality is a foundational aspect of Indigeneity. Drawing on research and experience, I will discuss the implications of relationality in maternal and child healthcare and how its application would benefit everyone within and outside this care setting.
Dr. Carina Venter
From the University of Colorado
Nutrition – Building Blocks for a Lifetime
Thursday, October 22, 2026
10:35 AM – 11:00 AM
Carina Venter is an allergy dietitian and professor of allergy specializing in immunonutrition, the microbiome, and food allergy prevention and management. She has held academic roles in the UK and US, including at the University of Colorado and Children’s Hospital Colorado. Her research focuses on early-life nutrition, diet diversity, and tolerance development. She has contributed to international guidelines with EAACI, AAAAI, NICE, and NIAID. Carina leads innovative work on food ladders, maternal diet, and microbiome-based strategies, and is actively building a clinical practice translating science into practical care for families.
Nutrition foundations for lifelong health will begin before birth. We will discuss maternal diet quality, diversity, and key nutrients shaping the infant microbiome and immune development. Emphasis will be placed on early nutritional exposures as critical building blocks influencing allergy risk, growth, and long-term health outcomes.
Dr. Karinne Muniz
From the University of Manitoba
Immune Proteins in Colostrum: Changes During Early Lactation and Association with Maternal Nutritional Status in a Pakistani Population
Thursday, October 22, 2026
11:05 AM – 11:20 AM
Dr. Karinne Muniz is a Pediatrician specializing in Neonatology, with years of experience in newborn care acquired in Brazil. Currently pursuing an MSc in the Department of Pediatrics and Child Health at the University of Manitoba, she combines her clinical expertise with a research-oriented approach to advance knowledge of breastfeeding and human milk.
My research investigates seven key colostrum immune proteins during the first 72 hours of lactation. Using samples from a clinical trial in Pakistan, I analyzed how maternal factors, including nutritional status, age, parity, and delivery mode, are associated with these bioactive components following pregnancy-related nutritional and antibiotic interventions.
Dr. Sanoji Wijenayake
From the University of Winnipeg
Mama Needs a Break: Investigating Milk-derived Extracellular Vesicles as Mediators of Maternal Stress and Environmental Enrichment
Thursday, October 22, 2026
11:25 AM – 11:50 AM
Dr. Sanoji Wijenayake (Ph.D.) is the Canada Research Chair in Milk Nanovesicles and Applied Health and is an Associate Professor of Cell and Molecular Biology at the University of Winnipeg. She established her research group at the Richardson College for the Environment and Sciences in January 2022 and studies the molecular and cellular underpinnings of how human milk shape offspring development and inflammatory responses during critical stages of postnatal development. Specifically, she studies a group of fat droplets, known as milk-derived extracellular vesicles (MEVs). MEVs are like small care packages that you receive from parents that are packed with bioactive goodies. Dr. Wijenayake has shown that MEVs readily get into the brain and peripheral tissues and have the potential to shape metabolism, immunity, inflammation, behaviour, and development of neonates. Dr. Wijenayake is passionate about uncovering the therapeutic potential of MEVs in the context of improving neonatal health.
Objectives:
1. Examine whether improving the living conditions of the nursing mothers, influence the composition of milk-derived extracellular vesicles.
2. Does environmental enrichment (EE) mitigate the negative outcomes of maternal immune activation visa vie milk-derived extracellular vesicles?
Dr. Mariette Chartier
From the University of Manitoba
Evaluating Mental Health Promotion Approaches for Manitoba Children and Families
Thursday, October 22, 2026
1:05 PM – 1:30 PM
Dr. Mariette Chartier is a Senior Scholar in the College of Community and Global Health at the University of Manitoba. Her main research interests are in the area of child and adolescent health, population mental health, and intervention research. She has authored over 70 peer-reviewed publications and 23 non-peer-reviewed reports. She has led government-funded reports on the Mental Health of Children in Manitoba, Mental Illness Among Adult Manitobans and the Health and Well-Being of First Nations Children.
This presentation will focus on lessons learned from evaluating two mental health promotion strategies for children and families. These include the cultural adaption and evaluation of the PAX-Good Behaviour in Northern First Nations schools and communities and through Manitoba’s public health system, the development and evaluation of the Towards Flourishing mental health promotion strategy for new parents.
Dr. Jo Ann Unger
From the University of Manitoba
Supporting Parents and Caregivers in a Digital World
Thursday, October 22, 2026
1:35 PM – 2:00 PM
Dr. Jo Ann Unger is a registered lifespan clinical psychologist, Assistant Professor in the Department of Clinical Health Psychology at the University of Manitoba, and Section Head of the Clinical Health Psychology Child and Adolescent Service. Her research focuses on evaluating the effectiveness of evidence-based resources in novel ways including in low-intensity formats, in particular providing families with the resources they need to support healthy child development and mental health. She is passionate about helping parents and caregivers develop the tools and skills to better support their children with a wide range of challenges including screen use.
Given the ubiquity of screen time as a focal point for family stress, we developed workshops to support parents and caregivers in applying evidence-based parenting strategies to this issue. These workshops were provided to caregivers in a Winnipeg school division. Pilot data from this project will be presented.
Dr. Patricia Conrod
From the Université de Montréal
To be determined
Thursday, October 22, 2026
2:05 PM – 2:30 PM
To be determined
To be determined
Dr. Brandy Wicklow
From the University of Manitoba
Generational Prevention — Looking Across the Lifespan to Reduce Type 2 Diabetes in Children
Thursday, October 22, 2026
2:35 PM – 3:00 PM
To be determined
This session will focus on the intergenerational impacts of type 2 diabetes on families, communities, and care pathways.
Following the session participants should be able to:
- Recognize the distinct risk factors for T2D in children
- List potential areas of growth in clinical and treatment pathways aimed to reduce risk
- Summarize key findings of the Next Generation birth cohort